14 results
8-K
EX-99.1
BPMC
Blueprint Medicines Corp
7 Sep 22
Regulation FD Disclosure
4:21pm
Biology, 2020. CNS, central nervous system. 15 Not for promotional use. EGFR - MUTANT NSCLC ESTIMATED INCIDENT PATIENTS PER YEAR70% OF PATIENTS PROGRESS
8-K
EX-99.1
BPMC
Blueprint Medicines Corp
8 Apr 22
Regulation FD Disclosure
1:20pm
NSCLC ESTIMATED INCIDENT PATIENTS PER YEAR70% OF PATIENTS PROGRESS TO 2L ~59,000 PATIENTS 1 Ex19del: ~33,000 L858R: ~26,000 1L 2L+ ~43,000 PATIENTS … ; and Harrison Seminars in Cancer Biology, 2020. CNS, central nervous system. 6 Not for promotional use. EGFR - MUTANT NSCLC ESTIMATED INCIDENT PATIENTS
8-K
EX-10.1
wy76 pjsm9
28 Jul 21
Other Events
4:15pm
8-K
EX-1.1
byhtsyd vf
23 Jan 20
Blueprint Medicines Announces Pricing of Public Offering of Shares of Common Stock
4:29pm
8-K
EX-1.1
5ifaxua96ic8tw31am
29 Mar 19
Blueprint Medicines Announces Pricing of Public Offering of Shares of Common Stock
4:24pm
- Prev
- 1
- Next